Vericel Corp. (VCEL)

[me33]

I've done my DD on AMRN and go by facts not guesstimates and wishful thinking.
"Robust Secondary data" is just an excuse AMRN uses to manage expectations and make investors believe that everything goes by the plan when the trial is not stopped at either interim as majority of ihub "experts" were predicting.
If it's all about secondary end points and trial goes to completion why did they insert a second interim and wasted money on it?
Btw I've been trading and following AMRN for years and made some good profits. I might jump in to ride another run up into final data release, but there's no way I'm holding through that binary event that will either make or break the company.
Finally, even if RI is successful there's a good chance AMRN will dilute to ramp up production and marketing. If you know AMRN you know how much they love to dilute while misleading investors about three options on the table.